Company Filing History:
Years Active: 2018-2022
Title: Innovations of Xiaojun Lu
Introduction
Xiaojun Lu is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules for therapeutic applications. With a total of 4 patents, his work focuses on innovative solutions for diseases associated with CD73 expression, such as cancer.
Latest Patents
One of Xiaojun Lu's latest patents is titled "Binding molecules specific for CD73 and uses thereof." This patent provides anti-CD73 binding molecules, including antibodies and their antigen-binding fragments. The disclosure also includes pharmaceutical formulations that comprise these compositions, along with methods for diagnosing and treating diseases linked to CD73 expression. The treatment options outlined in the patent include direct therapy with anti-CD73 binding molecules, adjuvant therapy with other anticancer agents, and combination therapies that may involve chemotherapy.
Career Highlights
Xiaojun Lu is currently employed at MedImmune Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative therapeutic strategies that target cancer and other diseases.
Collaborations
Xiaojun collaborates with notable colleagues, including Carl Hay and Kris Sachsenmeier, who contribute to his research initiatives and help drive innovation within the company.
Conclusion
Xiaojun Lu's contributions to the field of biotechnology and his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of cancer and other diseases associated with CD73 expression.